{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:38:22Z","timestamp":1770410302571,"version":"3.49.0"},"reference-count":63,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1586\/1744666x.2014.885381","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T06:01:20Z","timestamp":1391493680000},"page":"363-373","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Inflammatory bowel disease and demyelination: more than just a coincidence?"],"prefix":"10.1586","volume":"10","author":[{"given":"Aristeidis H","family":"Katsanos","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Ioannina, School of Medicine,","place":["Greece"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos H","family":"Katsanos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of Ioannina, School of Medicine,","place":["Greece"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,2,4]]},"reference":[{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1586\/eci.12.91"},{"issue":"4","key":"e_1_3_3_6_1","first-page":"181","article-title":"Biological agents targeting beyond TNF-alpha","volume":"12","author":"Sharma R","year":"2008","unstructured":"Sharma R, Sharma CL, Mahajan A. Biological agents targeting beyond TNF-alpha. Indian J Crit Care Med 2008;12(4):181-9","journal-title":"Indian J"},{"issue":"4","key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.gtc.2006.09.008","article-title":"Safety of infliximab and other biologic agents in the inflammatory bowel diseases","volume":"35","author":"Reddy JG","year":"2006","unstructured":"Reddy JG, Loftus EV Jr. Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Gastroenterol Clin North Am 2006;35(4):837-55","journal-title":"Gastroenterol Clin North Am"},{"issue":"11","key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1007\/s00296-011-2216-0","article-title":"A case of leukoencephalopathy associated with adalimumab-treated rheumatoid arthritis and a review of literature","volume":"32","author":"Ryu YS","year":"2012","unstructured":"Ryu YS, Park SH, Kim JM, et al. A case of leukoencephalopathy associated with adalimumab-treated rheumatoid arthritis and a review of literature. Rheumatol Int 2012;32(11):3481-55","journal-title":"Rheumatol Int"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0498-4"},{"key":"e_1_3_3_10_1","first-page":"2011","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF \u03b1 therapy for chronic plaque psoriasis","volume":"1","author":"Ahmed Z","year":"2011","unstructured":"Ahmed Z, Powell R, Llewelyn G, Anstey A. Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF \u03b1 therapy for chronic plaque psoriasis. BMJ Case Rep 2011;1:2011","journal-title":"BMJ Case Rep"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2113-2"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34468"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.10.005"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12385"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.23011"},{"issue":"4","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5114\/pjp.2012.32774","article-title":"Rare association of polyneuropathy and Crohn's disease: a clinicopathological study of 4 cases","volume":"63","author":"Kararizou E","year":"2012","unstructured":"Kararizou E, Davaki P, Speggos K, Stamboulis E. Rare association of polyneuropathy and Crohn's disease: a clinicopathological study of 4 cases. Pol J Pathol 2012;63(4):261-6","journal-title":"Pol J Pathol"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.1"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512461393"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj260"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20406"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2007.01452.x"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2011.03.004"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108153250704"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1531"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.3.457"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.021"},{"issue":"7","key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458510369146","article-title":"Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study","volume":"16","author":"Langer-Gould A","year":"2010","unstructured":"Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler 2010;16(7):855-61","journal-title":"Mult Scler"},{"issue":"4","key":"e_1_3_3_28_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.crohns.2008.04.001","article-title":"Occurrence of demyelinating diseases after anti-TNFalpha treatment of inflammatory bowel disease: a Danish Crohn Colitis Database study","volume":"2","author":"Andersen NN","year":"2008","unstructured":"Andersen NN, Caspersen S, Jess TMunkholm P. Occurrence of demyelinating diseases after anti-TNFalpha treatment of inflammatory bowel disease: a Danish Crohn Colitis Database study. J Crohns Colitis 2008;2(4):304-9","journal-title":"J Crohns Colitis"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2006.02.020"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2011.11.001"},{"issue":"4","key":"e_1_3_3_31_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.gene.6364303","article-title":"The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus","volume":"7","author":"De Jager PL","year":"2006","unstructured":"De Jager PL, Graham R, Farwell L, et al. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus. Genes Immun 2006;7(4):327-34","journal-title":"Genes Immun"},{"issue":"1","key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jneuroim.2007.11.011","article-title":"The interleukin 23 receptor gene in multiple sclerosis: a case-control study","volume":"194","author":"Roos IM","year":"2008","unstructured":"Roos IM, Kockum I, Hillert J. The interleukin 23 receptor gene in multiple sclerosis: a case-control study. J Neuroimmunol 2008;194(1-2):173-80","journal-title":"J Neuroimmunol"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2010.10"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.059428"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11307"},{"issue":"1","key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2007.11.015","article-title":"3'UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis","volume":"431","author":"Illes Z","year":"2008","unstructured":"Illes Z, Safrany E, Peterfalvi A, et al. 3'UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neurosci Lett 2008;431(1):36-8","journal-title":"Neurosci Lett"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.521"},{"issue":"5","key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00042737-200605000-00021","article-title":"Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy","volume":"18","author":"Dubcenco E","year":"2006","unstructured":"Dubcenco E, Ottaway CA, Chen DL, Baker JP. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy. Eur J Gastroenterol Hepatol 2006;18(5):565-6","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"e_1_3_3_39_1","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1007\/s10067-009-1154-7","article-title":"Guillain-Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy","volume":"28","author":"Bouchra A","year":"2009","unstructured":"Bouchra A, Benbouazza K, Hajjaj-Hassouni N. Guillain-Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy. Clin Rheumatol 2009;28(Suppl 1):S53-5","journal-title":"Clin Rheumatol"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.022"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.4065\/75.8.802"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20304"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/95.11.753"},{"issue":"2","key":"e_1_3_3_44_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000343188","article-title":"The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study","volume":"40","author":"Marrie RA","year":"2013","unstructured":"Marrie RA, Yu BN, Leung S, et al. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology 2013;40(2):85-92","journal-title":"Neuroepidemiology"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.047"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21290"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.05.010"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03882.x"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.04.001"},{"issue":"5","key":"e_1_3_3_50_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1155\/2005\/358658","article-title":"Demyelination-like syndrome in Crohn's disease after infliximab therapy","volume":"19","author":"Freeman HJ","year":"2005","unstructured":"Freeman HJ, Flak B. Demyelination-like syndrome in Crohn's disease after infliximab therapy. Can J Gastroenterol 2005;19(5):313-16","journal-title":"Can J Gastroenterol"},{"issue":"4","key":"e_1_3_3_51_1","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/brain\/awh429","article-title":"Peripheral neuropathy in patients with inflammatory bowel disease","volume":"128","author":"Gondim FA","year":"2005","unstructured":"Gondim FA, Brannagan TH 3rd, Sander HW, et al. Peripheral neuropathy in patients with inflammatory bowel disease. Brain 2005;128(Pt 4):867-79","journal-title":"Brain"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21814"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.11"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31822b7bb8"},{"issue":"1","key":"e_1_3_3_55_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2169\/internalmedicine.52.8452","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with Crohn's disease","volume":"52","author":"Ohyagi M","year":"2013","unstructured":"Ohyagi M, Ohkubo T, Yagi Y, et al. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with Crohn's disease. Intern Med 2013;52(1):125-8","journal-title":"Intern Med"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200401000-00004"},{"issue":"2","key":"e_1_3_3_57_1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejpn.2012.06.007","article-title":"Acute disseminated encephalomyelitis in conjunction with inflammatory bowel disease","volume":"17","author":"Aziz M","year":"2013","unstructured":"Aziz M, Stivaros S, Fagbemi A, Vassallo G. Acute disseminated encephalomyelitis in conjunction with inflammatory bowel disease. Eur J Paediatr Neurol 2013;17(2):208-11","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"e_1_3_3_58_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/ejpn.2002.0557","article-title":"Congenital Guillain-Barre syndrome associated with maternal inflammatory bowel disease is responsive to intravenous immunoglobulin","volume":"6","author":"Bamford NS","year":"2002","unstructured":"Bamford NS, Trojaborg W, Sherbany AA, De Vivo DC. Congenital Guillain-Barre syndrome associated with maternal inflammatory bowel disease is responsive to intravenous immunoglobulin. Eur J Paediatr Neurol 2002;6(2):115-19","journal-title":"Eur J Paediatr Neurol"},{"issue":"38","key":"e_1_3_3_59_1","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.3748\/wjg.v17.i38.4344","article-title":"Sudden blindness in a child with Crohn's disease","volume":"17","author":"Barabino AV","year":"2011","unstructured":"Barabino AV, Gandullia P, Calvi A, et al. Sudden blindness in a child with Crohn's disease. World J Gastroenterol 2011;17(38):4344-6","journal-title":"World J Gastroenterol"},{"issue":"3","key":"e_1_3_3_60_1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000143156","article-title":"Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone","volume":"77","author":"Charach G","year":"2008","unstructured":"Charach G, Grosskopf I, Weintraub M. Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone. Digestion 2008;77(3-4):198-200","journal-title":"Digestion"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i26.3638"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.211"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G134"},{"issue":"13","key":"e_1_3_3_64_1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.drudis.2007.05.001","article-title":"Alpha4-integrin antagonism\u2013an effective approach for the treatment of inflammatory diseases?","volume":"12","author":"Davenport RJMunday JR","year":"2007","unstructured":"Davenport RJMunday JR. Alpha4-integrin antagonism\u2013an effective approach for the treatment of inflammatory diseases? Drug Discov Today 2007;12(13-14):569-76","journal-title":"Drug Discov Today"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2008.12.005"},{"issue":"5","key":"e_1_3_3_66_1","first-page":"683","article-title":"Treatment of Crohn's disease with certolizumab pegol","volume":"3","author":"Winter TA","year":"2007","unstructured":"Winter TA, Sandborn WJ, de Villiers WJ, Schreiber S. Treatment of Crohn's disease with certolizumab pegol. Expert Rev Clin Immunol 2007;3(5):683-94","journal-title":"Expert Rev"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.09.005"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/1744666X.2014.885381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:57:32Z","timestamp":1770371852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/1744666X.2014.885381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,4]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1586\/1744666X.2014.885381"],"URL":"https:\/\/doi.org\/10.1586\/1744666x.2014.885381","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-02-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}